Feasibility of bevacizumab-IRDye800CW as a tracer for fluorescence-guided meningioma surgery. Dijkstra BM, Nonnekens J, Nagengast W, Kruijff S, et al. J Neurosurg 2022 Oct 28:1-10. doi: 10.3171/2022.9.JNS221036.

Read + Share

Amedeo Smart

Independent Medical Education

Dijkstra BM, Nonnekens J, Nagengast W, Kruijff S, et al. Feasibility of bevacizumab-IRDye800CW as a tracer for fluorescence-guided meningioma surgery. J Neurosurg 2022 Oct 28:1-10. doi: 10.3171/2022.9.JNS221036.
PMID: 36308486